SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $602,000 | -32.4% | 63,457 | -24.3% | 0.91% | -40.9% |
| Q2 2017 | $891,000 | -38.9% | 83,830 | +56.7% | 1.53% | -20.1% |
| Q1 2017 | $1,458,000 | +78.7% | 53,513 | +234.9% | 1.92% | +104.9% |
| Q4 2016 | $816,000 | +38.8% | 15,978 | +25.0% | 0.94% | +101.1% |
| Q3 2016 | $588,000 | +87.3% | 12,778 | -62.5% | 0.47% | +73.2% |
| Q2 2016 | $314,000 | – | 34,073 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |